Two Sigma Investments »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.7M 6.0M 1.28

More positions owned by Two Sigma Investments

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)
Metropcs Communications (TMUS)
Lockheed Martin Corporation (LMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Micron Technology (MU)
Adobe Systems Incorporated (ADBE)

View all positions for Two Sigma Investments

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Steelhead Partners
Bnp Paribas Arbitrage, Snc
Alberta Investment Management Corporation
DeepCurrents Investment Group
State Street Corporation
FMR
CSS
BlackRock
MacKay Shields
Manufacturers Life Insurance Company
Bank of America Corporation
Universal- Beteiligungs- und Servicegesellschaft mbH
Two Sigma Investments
Citigroup
Warberg Asset Management

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1